RICE HALL JAMES & ASSOCIATES, LLC – Ligand Pharmaceuticals Incorporated Transaction History
RICE HALL JAMES & ASSOCIATES, LLC portfolio value:
$25.54M
portfolio value
RICE HALL JAMES & ASSOCIATES, LLC quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -11.34% | -37.96K shares | -4.31M | $86.11 | 296.67K |
| Q2 2022 | share | Decrease | -2.99% | -10.32K shares | -8.94M | $89.22 | 334.64K |
| Q1 2022 | share | Decrease | -0.79% | -2.73K shares | -14.9M | $112.49 | 344.96K |
| Q4 2021 | share | Decrease | -6.96% | -26.02K shares | 1.63M | $156.16 | 347.69K |
| Q3 2021 | share | Decrease | -1.32% | -5.00K shares | 2.38M | $139.32 | 373.72K |
| Q2 2021 | share | Decrease | -11.94% | -51.33K shares | -15.87M | $131.19 | 378.72K |
| Q1 2021 | share | Decrease | -14.70% | -74.10K shares | 15.42M | $152.45 | 430.05K |
| Q4 2020 | share | Increase | +30.44% | 117.65K shares | 13.29M | $99.45 | 504.15K |
| Q3 2020 | share | Increase | +16.51% | 54.76K shares | -263K | $95.32 | 386.50K |
| Q2 2020 | share | Decrease | -1.96% | -6.63K shares | 12.49M | $111.85 | 331.74K |
| Q1 2020 | share | Increase | +11.86% | 35.87K shares | -6.94M | $72.72 | 338.37K |
| Q4 2019 | share | Decrease | -4.20% | -13.25K shares | 118K | $104.29 | 302.50K |
| Q3 2019 | share | Decrease | -2.01% | -6.49K shares | -5.35M | $99.54 | 315.75K |
| Q2 2019 | share | Decrease | -5.82% | -19.89K shares | -6.22M | $114.15 | 322.24K |
| Q1 2019 | share | Increase | +24.45% | 67.22K shares | 5.70M | $125.71 | 342.14K |
| Q4 2018 | share | Increase | +43.69% | 83.58K shares | -15.21M | $135.7 | 274.91K |
| Q3 2018 | share | Decrease | -28.32% | -75.58K shares | -2.78M | $274.49 | 191.33K |
| Q2 2018 | share | Decrease | -12.40% | -37.77K shares | 4.97M | $207.17 | 266.92K |
| Q1 2018 | share | Decrease | -0.71% | -2.16K shares | 8.30M | $165.16 | 304.69K |
| Q4 2017 | share | Increase | +14.49% | 38.84K shares | 5.52M | $136.93 | 306.85K |
| Q3 2017 | share | Decrease | -4.07% | -11.36K shares | 2.57M | $136.15 | 268.01K |
| Q2 2017 | share | Increase | +27.28% | 59.88K shares | 10.68M | $121.4 | 279.38K |
| Q1 2017 | share | Increase | +4.24% | 8.92K shares | 1.83M | $105.84 | 219.5K |
| Q4 2016 | share | Increase | +0.82% | 1.71K shares | 81K | $101.61 | 210.57K |
| Q3 2016 | share | Increase | +12.39% | 23.03K shares | -848K | $102.06 | 208.85K |
| Q2 2016 | share | Increase | +0.79% | 1.45K shares | 2.42M | $119.27 | 185.82K |
| Q1 2016 | share | Increase | +2.19% | 3.95K shares | 184K | $107.09 | 184.37K |